Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-21-000721
Filing Date
2021-10-22
Accepted
2021-10-22 20:09:26
Documents
1
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4101
  Complete submission text file 0000904454-21-000721.txt   5517
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Jacques Rachelle Suzanne (Reporting) CIK: 0001772610 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 211341899